42 web-programmer-developer-"INSERM" Fellowship positions at Nature Careers in United States
Sort by
Refine Your Search
-
The O’Connell lab studies regulation of intestinal and immune development in the premature infant and neonate. We currently have two projects that are in need of a postdoctoral fellow, and we will
-
the following things we are working on this may be the perfect opportunity: 1. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection
-
approaches and biochemical assays to target key proteins. This funded position is for a postdoctoral trainee interested in aiding the development of novel therapeutics for treating cancer or metabolic disease
-
of Health (NIH) and the Department of Health and Human Services (DHHS). Within this program, the Section on Synapse Development Plasticity (Chief: Zheng Li, PhD, https://www.nimh.nih.gov/research/research
-
to intervene the malignancies 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell sequencing chor high throughput proteomics 4) development of small molecule drugs and PROTAC
-
Imperial College Research Fellowship £48,056 - £56,345 per annum About the role: Imperial College London is promoting our exciting opportunity for outstanding early career researchers to develop
-
Postdoctoral Fellowship in AI and Large Language Models for Transforming Pediatric Healthcare The Computational Health Informatics Program (CHIP) at Boston Children's Hospital, affiliated with
-
at yzheng8@mdanderson.org. (1) a cover letter describing past contributions to the field, future research plan, career development plan, scientific motivation and interests that align with Dr. Zheng's lab, (2
-
Hepatology, Annals of Surgery , etc. Some of the key research topics in our laboratory include: Developing cell-free DNA (mutation and methylation) and RNA-based liquid biopsy biomarkers for cancer early
-
regulation and other aspects of cellular signal transduction. We use our structural and mechanistic insights to drive development of novel anti-cancer drugs. Systems of current interest in the lab include RAF